You might be given blood-thinning medications after you've had a stroke, to help you avoid another one. Or you might need blood-thinning medication if you have a health condition such as a heart problem or blood-clotting disorder which could lead to a stroke.
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initation could lead to fewer recurrent strokes.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
Stroke survivor and volunteer Emma Day shares her story and why volunteering is important.
Browse through a list of organisations that can provide support and information about reducing the risk of stroke.
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.
Techniques to predict - and in future prevent - brain haemorrhage in people treated with warfarin after stroke caused by atrial fibrillation
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association-funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study).